GLUSTIN

This brand name is authorized in Austria, Estonia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug GLUSTIN contains one active pharmaceutical ingredient (API):

1 Pioglitazone UNII JQT35NPK6C - PIOGLITAZONE HYDROCHLORIDE

Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance. Read about Pioglitazone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GLUSTIN Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BG03	Pioglitazone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1203118, 1203129, 1203130, 1203141, 1203152, 1203163, 1203174, 1203185, 1203196, 1203208, 1203219, 1203220, 1203231, 1213399, 1213401, 1213445, 1213456, 1213467, 1213478, 1213489, 1213490, 1213502, 1364464, 1364475
Country: IT	Agenzia del Farmaco	Identifier(s): 034958013, 034958049
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028680, 1028681, 1028682, 1028683, 1028684, 1028685, 1028686, 1028687, 1028688, 1028689, 1028690, 1028691, 1028692, 1028693, 1028694, 1028695, 1028696, 1028697, 1028698, 1028699, 1028700, 1028701, 1028702, 1028703
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100309875, 100309881, 100309898